Home > PS Ratio > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of PAR DRUGS AND CHEMICALS is 0.99.

Share Price ₹83.3May 21,2026
Market Cap ₹102.4 Cr
Sales-TTM₹103.7 CrTTM-Standalone Results
Price/Sales0.99xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of PAR DRUGS AND CHEMICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of PAR DRUGS AND CHEMICALS is calculated as :

Current Market Cap [ ₹102.4 Cr] as on May 21,2026

(/) Sales [ ₹103.7 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 0.99x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for PAR DRUGS AND CHEMICALS , the investors are currently willing to pay '0.99 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of PAR DRUGS AND CHEMICALS !

The chart below summarizes the trend in P/S Ratio of PAR DRUGS AND CHEMICALS over the last five years.

Historical PS (Price/Sales) ratio chart of PAR DRUGS AND CHEMICALS


PS Ratio Performance Analysis for PAR DRUGS AND CHEMICALS

- PAR DRUGS AND CHEMICALS 's latest p/e ratio is 0.99x.

- PAR DRUGS AND CHEMICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.89x.

- PAR DRUGS AND CHEMICALS 's operated at median p/e ratio of 1.8x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, PAR DRUGS AND CHEMICALS 's p/e ratio peaked in Mar2024 at 2.77x.

- PAR DRUGS AND CHEMICALS 's p/e ratio hit its five-year low in Mar2025 of 1.03x.


How does PAR DRUGS AND CHEMICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
PAR DRUGS AND CHEMICALS 103.70.99102.4
SUN PHARMACEUTICAL INDUSTRIES LTD56,809.17.99453,750.0
DIVIS LABORATORIES LTD10,314.017.66182,117.0
TORRENT PHARMACEUTICALS LTD12,742.011.88151,314.0
CIPLA LTD28,162.64.02113,225.0
DR REDDYS LABORATORIES LTD33,700.23.27110,037.0
MANKIND PHARMA LTD14,277.67.27103,845.0
LUPIN LTD27,958.03.74104,490.0
ZYDUS LIFESCIENCES LTD27,148.43.84104,266.0
AUROBINDO PHARMA LTD33,181.92.6888,979.3
LAURUS LABS LTD6,812.910.7072,918.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PAR DRUGS AND CHEMICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.99x
Max industry PS 17.66x
Median industry PS 4.02x
Average industry PS 6.73x



You may also like the below Video Courses